MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Penumbra Operating Expenses 2011-2026 | PEN
Annual Operating Expenses Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 753 M | 746 M | 609 M | 529 M | 483 M | 377 M | 324 M | 263 M | 216 M | 172 M | 120 M | 79.8 M | 59 M | 45.5 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 753 M | 45.5 M | 341 M |
Quarterly Operating Expenses Penumbra
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 192 M | 183 M | 176 M | 165 M | 244 M | 169 M | 165 M | 149 M | 143 M | - | 130 M | 134 M | 131 M | 166 M | 111 M | 108 M | 97.9 M | 96.1 M | 111 M | 82.6 M | 87.4 M | 87.5 M | 83 M | 81.1 M | 72.8 M | 72 M | 95.9 M | 63 M | 62.5 M | 59.9 M | 54.1 M | 52.3 M | 49.8 M | - | 44.2 M | 42.1 M | 38.1 M | - | 31.3 M | 31.2 M | 22.7 M | - | 20.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 244 M | 20.5 M | 100 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.13 | -1.39 % | $ 1.29 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 11.44 | 3.81 % | $ 410 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 25.21 | -1.6 % | $ 213 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.49 | 4.49 % | $ 131 M |  France |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 46.15 | -15.91 % | $ 1.36 B | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.25 | 0.63 % | $ 319 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 57.82 | -2.12 % | $ 3.15 B |  Britain |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.63 | 0.87 % | $ 39.2 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.07 | -1.38 % | $ 18.1 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Insulet Corporation
PODD
|
531 M | $ 169.07 | -1.35 % | $ 11.9 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.05 | 1.71 % | $ 377 M | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.38 | 0.42 % | $ 6.6 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.96 | 2.37 % | $ 1.05 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 91.09 | 0.54 % | $ 12.3 B | USA |
 |
NanoVibronix
NAOV
|
23 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.07 | 0.45 % | $ 1.12 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 86.83 | 3.36 % | $ 3.02 B | USA |
 |
TransMedics Group
TMDX
|
254 M | $ 96.34 | -0.76 % | $ 3.27 B | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 295.54 | 1.54 % | $ 113 B | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 19.25 | -3.12 % | $ 1.31 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 82.79 | -0.65 % | $ 48.4 B | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.51 | -0.9 % | $ 65.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.26 | -5.26 % | $ 51.3 M | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 3.71 | 2.77 % | $ 548 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.85 | -1.1 % | $ 35.6 M | USA |